Are Multicancer Early Detection Tests More Hype Than Help?
New tests that detect multiple cancers with a single blood draw promise to revolutionize cancer screening, but they have also raised many unanswered questions.
New tests that detect multiple cancers with a single blood draw promise to revolutionize cancer screening, but they have also raised many unanswered questions.
Christine Bestvina, MD, presents a case of a 34-year-old non-smoker diagnosed with Stage IIIA NSCLC after presenting with chest wall pain; the panel then explores…
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies,…
Enzalutamide alone and with leuprolide led to greater rates of undetectable PSA levels vs leuprolide alone in castration-sensitive prostate cancer.
The ASH Hematology Review Series is designed for fellows preparing to take the internal medicine hematology certification exam or those desiring a comprehensive update of…
Adnan Khattak, MBBS, FRACP, Royal Perth Hospital, Perth, Australia, explores the emerging treatment strategies for PD-1 refractory melanoma, including neoadjuvant therapy. Preoperative immune checkpoint inhibitors…
Halle B #148 [Abstract] Thu 9 May 1:45 a.m. PDT — 3:45 a.m. PDT Abstract: The visual examination of tissue biopsy sectio ns is fundamental…
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
18F-PSMA-1007 PET/CT generated superior locoregional staging results vs multiparametric MRI in patients with prostate cancer.
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women…